View drug registration information details.


ItemsRegistration information
ID248
No248
Brand NamePOMMADX
IngredientsPOMALIDOMIDE 2 MG
Dosage FormCAPSULE
Primary PackagingBOTTLE
StorageSTORE BELOW 30 C
Shelf Life2 YEARS
Pack SizeBOX OF 21 TABLET'S
Dispensing CategoryPRESCRIPTION
ATC Classification
Pharmaceutical ClassANTINEOPLASTIC
IndicationsUSED IN COMBINATION WITH DEAMETHASONE TO TREAT MULTIPLE MYELOMA (A TYPE OF CANCER OF THE BONE MARROW) THAT HAS NOT IMPROVED DURING OR WITHIN 60 DAYS OF TREATMENT WITH AT LEAST TWO OTHER MEDICATIONS INCLUDING LENALIDOMIDE AND PROTEASOME INHIBITOR.
Contraindications
Side Effects
Unit Price
EDL No
DescriptionBLUE CAPSULE
Note
License OwnerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
ManufacturerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No10 L 1022/23
FDD Registration Date2023-10-10
Expiry Date2026-10-09

Back to drug list